Dr. Byram Bridle Viral Immunologist: New Peer Reviewed Study On The mRNA Injections Are Scary

“As someone who develops vaccines, I can tell you that it is difficult to make a vaccine that will perform as poorly as the current COVID-19 vaccines.”

“I would probably prefer to have natural immunity”

Dr Bridle a Canadian viral immunologist and associate professor started speaking out when the school for his young special needs son wanted the child to be quarantined for two weeks because another child tested ‘positive’. “Why do we have to put him in solitary confinement?” asked his older son.

Editor: One glance at Dr Bridle’s sweet young son is enough to know that solitary confinement would be a cruel punishment deemed illegal and inhumane in any prison for adult convicts! Watch his recent October 2021 speech in Toronto and meet his little boy here.

Dr Bridle:

I spent my career developing vaccines. I have never received any research funding from any industry sources. I have received funding from the government agencies that I have listed here. So we have two federal funding agencies, the Canadian Institutes of Health Research, and another one, the Natural Sciences and Engineering Research Council of Canada.

These are actually dedicated towards some basic fundamental research on viral immunology and they, and developing vaccines for cancers. Now, what I want to point out is that… Oh, and then I had some funding from the Canada Foundation for Innovation for equipment that I purchased. And then the last two that you see listed here are actually dedicated towards COVID-19 research.

So I do have a COVID-19 vaccine development program going on. And the vaccines that we’re developing realistically wouldn’t be able to go into human clinical trials for at least another year and a half, maybe two years…
So I I’m a viral immunologist. That means I have expertise in the fields of virology and immunology…
And so with that said, I just want to differentiate two terms we’ve been hearing a lot about during this pandemic:
1. One is anti-vaxxers. And usually when that term is used, it’s often referring to people who tend to hold an extremely negative view of all vaccines, regardless of what the scientific data has to say about them.

2. But I want to highlight that vaccine hesitancy is very, very different. And a lot of people who have the vaccine hesitancy are being made to feel very bad these days, right? It’s as though if they were simply educated enough about vaccines, then they would have no problem with these COVID-19 vaccines. But that’s not the case. That’s not the definition, certainly that I use. These are individuals instead who are unsure of their commitment to taking a vaccine. And it’s usually because of outstanding questions. So in other words, the onus is not on the individual. It’s not that the individual simply needs to be educated. We have, there’s lots of people who are very deep thinkers about this, doing their own research about the COVID-19 vaccines and coming up with very legitimate questions.

Dr Bridle, In a presentation to the New Zealand Covid Plan B group

From May 2021, 9 minutes.

Open letter to the president of the University of Guelph from Dr. Byram Bridle, October 6, 2021

Dear Dr. Charlotte A.B. Yates, President and Vice-Chancellor,

You issued a mandate that everyone within the University of Guelph community must receive a COVID-19 vaccine. I have spent most of my lifetime learning to be a very deep and critical thinker and to follow the weight of scientific evidence. I am a well-recognized expert in vaccinology. As per my extensive funding, research, publication, and teaching records, I am a vaccine lover and an innovator in this field. I promote highly effective vaccines that have undergone extensive, rigorous, and proper safety testing as the most efficient type of medicines that exist. Vaccines that meet these criteria have prevented a vast amount of mortality and morbidities around the world. However, I could not be in stronger disagreement with you forcing the current COVID-19 vaccines upon everyone who is part of our campus community.

Read the rest of the full open letter here. Or, listen to the full open letter read out on the Tom Woods Show here.

About Byram W. Bridle Associate Professor, PhD

Dr. Bridle is a viral immunologist who is passionate about improving life through two avenues of research. One arm of his research program is dedicated to designing and optimizing novel biotherapies for the treatment of cancers. The goal of his research team is to harness the natural power of a patient’s immune system to eliminate their own cancer cells. This represents the ultimate personalized therapy and holds the potential to treat cancers more effectively, safely, and at lower cost than current options. The second arm of his research program focuses on studying host responses to viruses and other inflammatory stimuli. This has implications for the treatment of infectious diseases and inflammation-mediated disorders. These two programs have been unified in a unique way. The Bridle lab is harnessing their expertise in making potent cancer vaccines and combining this with their interest in anti-viral immunity to develop vaccines to protect against infectious diseases such as those caused by highly pathogenic coronaviruses. Mentoring the next generation of Canadian scientists is a responsibility that Dr. Bridle takes very seriously. He also counts it a privilege to teach students in the Doctor of Veterinary Medicine, graduate and undergraduate programs at the University of Guelph.

Research Interests

          The research program in the Bridle lab has two arms. One is to develop novel, highly targeted biotherapies for the treatment of cancers. In an effort to kill malignant cells with minimal bystander damage to normal tissues, two approaches are combined: (a) cancer immunotherapy that directs the power of a patient’s immune system against their own tumour(s) and, (b) oncolytic virotherapy, which utilizes viruses that replicate in and kill only cancerous cells. The exquisite specificity, systemic targeting capability and short treatment windows of these therapies hold promise that cancer patients might be effectively treated with reduced side-effects and at minimal cost. The goal is to translate the most promising iterations of these therapies into clinical trials in companion animals as a stepping stone towards testing in human patients. A second emphasis of the lab is the study of host responses to viruses. An area of focus is developing a better understanding of the mechanisms underlying virus-induced cytokine storms. Dr. Bridle’s research team has identified a critical role of signaling through the type I interferon receptor in the negative regulation of an extensive network of cytokines. Cytokine responses to viruses are often very different between females and males and the Bridle lab group is seeking to understand why. At the intersection of these two programs, is a research initiative aimed at modifying the research team’s optimized cancer vaccine platforms to target severe acute respiratory syndrome coronavirus (SARS-CoV)-2, which is the causative agent of the coronavirus disease identified at the end of 2019 (COVID-19). The long-term goal is to have a flexible technological platform to rapidly develop vaccines against highly pathogenic coronaviruses that may emerge in the future. 

          The Bridle lab seeks researchers who are collaborative, highly motivated, innovative, hard-working and want to have a significant impact in the field of viral immunology. An outstanding academic record, excellent writing and oral presentation skills and a collaborative approach are essential. Trainees will have an opportunity to gain valuable, hands-on research experience in a variety of areas. Learning the fundamental principles of immunology, cancer biology and/or virology is an emphasis. Applicants who are willing to work longer hours than average, are passionate about pursuing a career in research, are excellent communicators, punctual, autonomous and possess excellent technical skills will excel in this laboratory. In return, members can expect diligent mentorship, access to state-of-the-art research resources, with opportunities spanning the basic to translational research spectrum, giving them the resources needed to potentially publish in the highest impact scientific journals and placing the future of their research career in their own hands. Prospective trainees should submit a curriculum vitae, transcripts (unofficial copies would suffice) and a cover letter explaining how they could help advance the research mandates of this laboratory.


Research Funding:

The Bridle lab is or has been funded by:

  • Canadian Institutes of Health Research
  • Natural Sciences and Engineering Research Council of Canada (NSERC)
  • Terry Fox Research Institute
  • Canadian Cancer Society,
  • Cancer Research Society
  • Canadian Breast Cancer Foundation
  • Ontario COVID-19 Rapid Reserach Fund
  • University of Guelph/Ontario Veterinary College/Department of Pathobiology COVID-19 Seed Funding
  • National Centre of Excellence in Biotherapeutics for Cancer Treatment (BioCanRx)
  • OVC Pet Trust
  • The Smiling Blue Skies Cancer Fund
  • Canadian Foundation for Innovation – John R. Evans Leaders Fund
  • Canadian Foundation for Innovation – Infrastructure Operating Funds
  • Ministry of Research and Innovation Ontario Research Fund – Research Infrastructure Program

The Bridle lab is part of the…

  • Canadian Oncolytic Virus Consortium
  • Network of Centre of Excellence in Biotherapies for Cancer Treatment (founding member)
  • Canadian Society for Immunology
  • Canadian Society for Virology
  • Terry Fox Research Institute
  • Institute for Comparative Cancer Investigation
  • Dog Osteosarcoma Group: Biomarkers/Biotherapy Of Neoplasia (DOGBONe)
  • One Health Institute

Teaching

  • VETM*3080  Veterinary Physiology and Biochemistry (Head Instructor: Veterinary Immunology)
  • VETM*3450  Principles of Disease in Veterinary Medicine (Immunology Review Lecture)
  • BIOM*4150/6702  Cancer Biology (Tumour Immunology Unit)
  • BIOM*6800  Gene Expression in Health and Disease (Lecture: “Identification of genes encoding tumour-associated antigens and their use in cancer vaccine design”)
  • PABI*6104  Mechanisms of Disease (Lecture: “Oncolytic and Immunotherapies”)
  • BIOM*4521/2  Research in Biomedical Sciences
  • BIOM 4500  Research in Biomedical Sciences Literature Review
  • HK*4371/2  Research in Human Biology and Nutritional Sciences
  • TOX*4900/10  Research Project
  • PABI*6960  Special Topics in Pathobiology
  • CLIN*6560 – Small Animal Internal Medicine II (Immunology Review Lecture)

Professional Experience & Honours

Dr. Bridle received graduate training in immunology at the University of Guelph and then postdoctoral training as a viral immunologist at McMaster University.

Some of Dr. Bridle’s noteworthy honours include:

  • The Carl J. Norden Distinguished Teaching Award. This is the highest teaching award given by each North American Veterinary College; the recipient is chosen based on a vote of the second, third and fourth year veterinary classes.
  • Terry Fox Research Institute New Investigator Award
  • Being elected to be an honourary class president for the Ontario Veterinary College’s Doctor of Veterinary Medicine classes of 2017 (Violet Komodos) and 2023 (Opal Otters)
  • Zoetis Award for Research Excellence

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *

Scroll Up